ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
Home » Events

SDBDG BioTalk: Nuvasive

Submitted by on December 29, 2008 – 9:17 am

San Diego Biotechnology Discussion Group’s January BioTalk: Nuvasive, January 28, 2009, 5:30-8:00 p.m., Sorrento Summit (adjacent to Nuvasive HQ)

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.